Early discharge after transfemoral transcatheter aortic valve implantation

Heart

Volumn 101, Issue 18, 2015, Pages 1485-1490

  Barbanti, Marco ^a   Capranzano, Piera ^a   Ohno, Yohei ^a   Attizzani, Guilherme F ^a   Gulino, Simona ^a   Immè, Sebastiano ^a   Cannata, Stefano ^a   Aruta, Patrizia ^a   Bottari, Vera ^a   Patanè, Martina ^a   Tamburino, Claudia ^a   Di Stefano, Daniele ^a   Deste, Wanda ^a   Giannazzo, Daniela ^a   Gargiulo, Giuseppe ^a   Caruso, Giuseppe ^a   Sgroi, Carmelo ^a   Todaro, Denise ^a   Di Simone, Emanuela ^a   Capodanno, Davide ^a   Tamburino, Corrado ^a,b   more..

^a UNIVERSITY OF CATANIA   (Italy)

^b ETNA Foundation   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AORTA VALVE DISEASE; AORTA VALVE PROSTHESIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; CONTROLLED STUDY; DEATH; FEASIBILITY STUDY; FEMALE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PATIENT SAFETY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR DISEASE; ADVERSE EFFECTS; AORTIC VALVE STENOSIS; LENGTH OF STAY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RISK ASSESSMENT; STANDARDS; STATISTICS AND NUMERICAL DATA; TIME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; FEASIBILITY STUDIES; FEMALE; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PACEMAKER, ARTIFICIAL; PATIENT DISCHARGE; PATIENT READMISSION; POSTOPERATIVE COMPLICATIONS; RISK ADJUSTMENT; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84941569670     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2014-307351     Document Type: Article

References (15)

1. Kodali SK, Williams MR, Smith CR, et al., PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012;366:1686-95.
2. Makkar RR, Fontana GP, Jilaihawi H, et al., PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012;366:1696-704.
3. Adams DH, Popma JJ, Reardon MJ, et al., U. S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014;370:1790-8.
4. Mylotte D, Osnabrugge RL, Windecker S, et al. Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization. J Am Coll Cardiol 2013;62:210-19.
5. Reynolds MR, Magnuson EA, Wang K, et al., PARTNER Investigators. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (Cohort B). Circulation 2012;125:1102-9.
6. D'Errigo P, Barbanti M, Ranucci M, et al., OBSERVANT Research Group. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study. Int J Cardiol 2013;167:1945-52.
7. Leipsic J, Gurvitch R, Labounty TM, et al. Multidetector computed tomography in transcatheter aortic valve implantation. JACC Cardiovasc Imaging 2011;4:416-29.
8. Barbanti M, Sgroi C, Immè S, et al. Usefulness of contrast injection during balloon aortic valvuloplasty before transcatheter aortic valve replacement: a pilot study. Eurointervention 2014;10:241-7.
9. Ielasi A, Latib A, Tespili M. Current and new-generation transcatheter aortic valve devices: an update on emerging technologies. Expert Rev Cardiovasc Ther 2013;11:1393-405.
10. Ussia GP, Scarabelli M, Mulè M, et al. Postprocedural management of patients after transcatheter aortic valve implantation procedure with self-expanding bioprosthesis. Catheter Cardiovasc Interv 2010;76:757-66.
11. Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012;60:1438-54.
12. Reynolds MR, Magnuson EA, Lei Y, et al., PARTNER Investigators. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol 2012;60:2683-92.
13. Babaliaros V, Devireddy C, Lerakis S, et al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc Interv 2014;7:898-904.
14. Durand E, Eltchaninoff H, Canville A, et al. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards Sapien-XT prosthesis. Am J Cardiol 2015;115:1116-22.
15. Siontis GC, Jüni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol 2014;64:129-40.